retatrutide clinical trial side effects 🔬 — why cardiology and the gym are paying attention For years, peptides lived in bro science or medicine — rarely both. TRIUMPH-4 (Phase 3) changed that. Topline signals: • ~30% Retatrutide Side Effects: Risks and

Fatigue and low energy Semaglutide-related fatigue affects some users in the first week or two

The 2025 JAHA meta-analysis examined the GLP-1 class as a whole and did not find statistically significant differences between individual medications for DVT risk

Retatrutide: Triple Agonist Framework Retatrutide activates: GLP-1R GIPR GCGR Triple agonist compounds introduce expanded metabolic signaling complexity and allow broader receptor cross-talk analysis

The mechanism was biologically plausible

Most people regain approximately two-thirds of their lost weight within one year of stopping GLP-1 therapy

Reviewed May 2026